Anthropic says Claude helped create 17 protein designs that met its criteria for binding dangerous scorpion toxins, but the company does not claim they work as antivenom.
The Anthropic research says Claude generated 318,484 candidates. Adaptyv Bio and Twist Bioscience tested 211, with qualifying binders found for four toxins. None qualified for Ts1, and designs aimed at multiple toxins failed to bind more than one.
The main limit is neutralization. Anthropic tested binding to recombinant toxins, not whether the proteins stop venom in cells or animals. Its strongest candidate showed single-digit nanomolar affinity or better and competed with a known neutralizing antibody, but that is still an early lab signal rather than evidence of an antidote.